No article text was recorded for this version.
innate immune checkpoint blockade
Version 2 of 216 papers21 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)
- Blog: Ovarian cancer stem cells: Critical roles in anti-tumor immunity
- Blog: Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
- Blog: Exploiting innate immunity for cancer immunotherapy
- Blog: 1364 Discovery of NXA01, a novel CD24 antibody with tumor selectivity and potent anti-tumor activity
- Blog: Tumor-Associated Macrophages: Recent Insights and Therapies
- Blog: The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
- Blog: 859 Combination of HER2 ADC and lemzoparlimab elicits enhanced efficacy in both HER2 high-and low-expressing breast and gastric cancers
- Blog: Synergistic enhancement of efferocytosis and cholesterol efflux via macrophage biomimetic nanoparticle to attenuate atherosclerosis progression
- Blog: ENPP1 is an innate immune checkpoint of the anticancer cGAMP–STING pathway in breast cancer
- Blog: PD-1 regulates the anti-tumor immune function of macrophages through JAK2-STAT3 signaling pathway in colorectal cancer tumor microenvironment
- Blog: Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon
- Blog: Cancer stem cells: a target for overcoming therapeutic resistance and relapse
- Blog: Progress in cancer research on the regulator of phagocytosis CD47, which determines the fate of tumor cells (Review)
- Blog: 793 Treatment of anti-SIRPα in combination with anti-TAA exerts superior anti-tumor activity
- Blog: Low-dose statins restore innate immune response in breast cancer cells via suppression of mutant p53
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_innate_immune_checkpoint_blockade_8271c901,
title = {innate immune checkpoint blockade},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/innate-immune-checkpoint-blockade/rdr_8271c901456e4d79909d34a829e67b62},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_innate_immune_checkpoint_blockade_8271c901_v2,
title = {innate immune checkpoint blockade},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/innate-immune-checkpoint-blockade/rdr_8271c901456e4d79909d34a829e67b62/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}